Rioux Jean-Philippe, De Bortoli Bruno, Quérin Serge, Déziel Clément, Troyanov Stéphan, Madore François
Nephrology Division, Hôpital du Sacré-Coeur de Montréal, Montreal, Québec H4J 1C5 Canada.
J Vasc Access. 2009 Jul-Sep;10(3):180-2. doi: 10.1177/112972980901000308.
Accurate measurement of the international normalized ratio (INR) may be difficult in hemodialysis (HD) patients with heparin-locked central catheters. Blood contamination with locking solutions may interfere with INR measurement when samples are collected directly from the catheter.
The aim of our study was to evaluate a novel sampling method for the measurement of INR in HD patients with heparin-locked central catheters. This novel method consists of measuring the INR directly from the dialysis circuit (arterial bloodline sample port) after 1 hr of treatment regardless of heparin administration during dialysis. We compared this method to the gold standard (peripheral venipuncture prior to dialysis) using the paired t-test. We included 30 patients (23 with warfarin therapy and 7 without).
INRs obtained using the novel sampling method were only minimally overestimated compared to venipuncture values (mean INR overestimation: 0.2 +/- 0.2). This overestimation was not clinically significant and did not lead to changes in warfarin prescription for any of the patients. Correlation tests confirmed the influence of heparin administration on INR overestimation (R=0.4; p=0.05). This influence was present mostly among patients receiving more than 100 Units/kg of heparin during their treatment.
This novel sampling technique provides a convenient and simple method of monitoring INR among HD patients.
对于使用肝素封管的中心静脉导管进行血液透析(HD)的患者,准确测量国际标准化比值(INR)可能存在困难。当直接从导管采集样本时,封管溶液导致的血液污染可能会干扰INR测量。
我们研究的目的是评估一种用于测量使用肝素封管的中心静脉导管的HD患者INR的新采样方法。这种新方法包括在治疗1小时后直接从透析回路(动脉血路样本端口)测量INR,而不考虑透析期间是否使用肝素。我们使用配对t检验将这种方法与金标准(透析前外周静脉穿刺)进行比较。我们纳入了30名患者(23名接受华法林治疗,7名未接受)。
与静脉穿刺值相比,使用新采样方法获得的INR仅被轻微高估(平均INR高估:0.2±0.2)。这种高估在临床上不显著,并且没有导致任何患者的华法林处方改变。相关性测试证实了肝素给药对INR高估的影响(R = 0.4;p = 0.05)。这种影响主要存在于治疗期间接受超过100单位/千克肝素的患者中。
这种新的采样技术为监测HD患者的INR提供了一种方便且简单的方法。